Latest Announcements

VEDAVAAG Systems Ltd has scheduled a Board Meeting on August 14, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026.

Jhaveri Credits & Capital Ltd has scheduled a Board meeting on August 12, 2026, to consider and approve the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026.

Deepak Fertilisers & Petrochemicals Corporation Ltd's Q1 FY 2027 earnings conference call transcript is available on the company's website, with management discussing a 65% jump in operating EBITDA and doubling of PAT, despite volatility from the Middle East war. The company's integrated value chain and alignment with India's growth story are highlighted as key strengths.

MPDL Ltd has scheduled a board meeting on August 13, 2026, to consider and approve the standalone and consolidated un-audited financial results for the quarter ended June 30, 2026.

Garlon Polyfab Industries Ltd has scheduled a board meeting on August 14, 2026, to consider and approve the unaudited standalone financial results for the quarter ended June 30, 2026.

Mold-Tek Technologies Ltd has announced its un-audited financial results for the first quarter ended June 30, 2026, with revenue from operations at ₹4,551.93 lakhs and total income at ₹4,796.29 lakhs. The company's expenses include employee benefits expense of ₹2,605.79 lakhs, finance costs of ₹9.78 lakhs, and depreciation and amortisation expenses of ₹134.65 lakhs.

Satyam Silk Mills Ltd has scheduled a board meeting on August 12, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026.

Sudarshan Colorants India Ltd has published unaudited standalone financial results for the quarter ended June 30, 2026, in newspapers as required by SEBI regulations.

Procter & Gamble Health Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with sales up 7% and PAT up 45% compared to the same period last year.

Mid East Portfolio Management Ltd has scheduled a Board Meeting on 11/08/2026 to consider and approve the unaudited standalone financial result for the first quarter ended on 30th June, 2026.

Maithan Alloys Ltd published revised standalone and consolidated audited financial results for the quarter and financial year ended on 31st March, 2026, in compliance with Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Procter & Gamble Health Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with a profit before tax of ₹12,912 lakhs, a 9.3% increase from the previous quarter's ₹11,811 lakhs. The company's total income was ₹37,459 lakhs, a 0.4% increase from the previous quarter's ₹37,045 lakhs. Expenses for the quarter were ₹27,027 lakhs, a 12.1% decrease from the previous quarter's ₹30,727 lakhs.

IL&FS Investment Managers Ltd has scheduled a board meeting on August 13, 2026, to consider and approve the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026.

SRG Housing Finance Ltd has published unaudited financial results for the quarter ended June 30, 2026, as per the Regulation 30 (LODR) of the BSE. The results were published in the financial Express-Delhi Edition (English) and Business remedies (Hindi) on August 06, 2026.

Grauer & Weil India Ltd-$ has published unaudited financial results for the quarter ended 30th June, 2026, in newspapers as per Regulation 47 of SEBI (LODR) Regulations, 2015.

Procter & Gamble Health Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with revenue from operations at ₹3,637.7 lakhs, total income at ₹36,759 lakhs, and profit before tax at ₹12,912 lakhs.

Trent Ltd announces rotation of statutory auditors in FY 2027-28, with Deloitte Haskins & Sells LLP completing their second term and B S R & Co. LLP being appointed as the new statutory auditors for a term of five consecutive years.

Emcure Pharmaceuticals Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, showing a strong all-round performance with increased revenue, EBITDA, and PAT. The company has also announced key leadership changes, including the appointment of Mr. Satish Mehta as Chairman and Mr. Samit Mehta as COO, and the elevation of Gennova Biopharmaceuticals to a wholly-owned subsidiary.

Edelweiss Financial Services Ltd has announced its earnings update for the first quarter ended June 30, 2026, with a consolidated PAT of $13 Mn, a 83% YoY growth. The company's Alternative Asset Management Fee Paying AUM grew by 27% YoY to $5,140 Mn, and Mutual Fund Equity AUM increased by 32% YoY to $10,148 Mn. The company's total customer reach increased to 14 Mn, up 30% YoY, and customer assets at $30 Bn, up 23% YoY.

Arfin India Ltd has scheduled a board meeting on August 11, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026. The trading window for directors and key managerial personnel has been closed from July 1, 2026, till August 13, 2026.